FDA Inspection
STAQ Pharma of Ohio, LLCSTAQ Pharma of Ohio, LLC – FDA Inspection, Aug 19, 2026
Record Details
This FDA Inspection record concerns STAQ Pharma of Ohio, LLC, with an inspection on August 19, 2026, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · ceeb8f4c-b66a-489b-b1a1-16286240d87a
Inspection Facts
- Inspection number
- 1331724
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.188(b)(5)In-process and laboratory control results
Full citation text and observation details available on the Dashboard.
Other FDA inspections of STAQ Pharma of Ohio, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2025 | VAI | Cincinnati District Office | Drug Quality Assurance |
| October 4, 2023 | VAI | Drug Quality Assurance |
Other documents for STAQ Pharma of Ohio, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.